Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Analgesia, Obstetrical | 14 | 2022 | 48 | 4.300 |
Why?
|
| Analgesia, Epidural | 10 | 2022 | 48 | 3.310 |
Why?
|
| Cesarean Section | 15 | 2019 | 114 | 2.920 |
Why?
|
| Pain, Postoperative | 9 | 2019 | 199 | 1.940 |
Why?
|
| Anesthesia, Spinal | 8 | 2016 | 23 | 1.810 |
Why?
|
| Pregnancy | 26 | 2022 | 961 | 1.520 |
Why?
|
| Labor, Obstetric | 6 | 2022 | 35 | 1.370 |
Why?
|
| Anesthesia, Epidural | 7 | 2016 | 21 | 1.270 |
Why?
|
| Anesthesia, Obstetrical | 7 | 2016 | 17 | 1.150 |
Why?
|
| Analgesia, Patient-Controlled | 4 | 2017 | 18 | 1.130 |
Why?
|
| Post-Dural Puncture Headache | 2 | 2022 | 3 | 0.850 |
Why?
|
| Needles | 4 | 2010 | 29 | 0.760 |
Why?
|
| Fentanyl | 2 | 2017 | 33 | 0.750 |
Why?
|
| Neostigmine | 3 | 2017 | 19 | 0.670 |
Why?
|
| Adult | 27 | 2019 | 9259 | 0.660 |
Why?
|
| Pain Measurement | 6 | 2019 | 341 | 0.650 |
Why?
|
| Female | 33 | 2022 | 19945 | 0.630 |
Why?
|
| Bupivacaine | 3 | 2017 | 51 | 0.630 |
Why?
|
| Delivery, Obstetric | 5 | 2013 | 53 | 0.610 |
Why?
|
| Obesity, Morbid | 2 | 2014 | 72 | 0.580 |
Why?
|
| Labor Pain | 3 | 2009 | 10 | 0.570 |
Why?
|
| Eclampsia | 2 | 2009 | 3 | 0.550 |
Why?
|
| Analgesics | 2 | 2009 | 111 | 0.500 |
Why?
|
| Humans | 34 | 2022 | 32282 | 0.500 |
Why?
|
| Equipment Failure | 1 | 2016 | 25 | 0.490 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 2006 | 26 | 0.460 |
Why?
|
| Analgesics, Opioid | 5 | 2017 | 252 | 0.440 |
Why?
|
| Spinal Puncture | 2 | 2004 | 22 | 0.390 |
Why?
|
| Anesthetics, Local | 3 | 2017 | 85 | 0.390 |
Why?
|
| Private Practice | 1 | 2013 | 3 | 0.390 |
Why?
|
| Back Pain | 2 | 2004 | 26 | 0.390 |
Why?
|
| Headache | 2 | 2004 | 72 | 0.380 |
Why?
|
| Cholinesterase Inhibitors | 2 | 2009 | 37 | 0.370 |
Why?
|
| Seizures | 2 | 2009 | 65 | 0.350 |
Why?
|
| Epidural Space | 1 | 2010 | 8 | 0.320 |
Why?
|
| Young Adult | 7 | 2016 | 2649 | 0.310 |
Why?
|
| Sodium Chloride | 1 | 2009 | 25 | 0.300 |
Why?
|
| Subcutaneous Emphysema | 1 | 2009 | 4 | 0.300 |
Why?
|
| Edema | 1 | 2009 | 29 | 0.290 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2008 | 4 | 0.280 |
Why?
|
| Antiemetics | 1 | 2008 | 5 | 0.280 |
Why?
|
| Ondansetron | 1 | 2008 | 5 | 0.280 |
Why?
|
| Dexamethasone | 1 | 2008 | 46 | 0.280 |
Why?
|
| Patient Discharge | 1 | 2008 | 204 | 0.250 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 2006 | 2 | 0.250 |
Why?
|
| Ebstein Anomaly | 1 | 2006 | 2 | 0.250 |
Why?
|
| Pregnancy Complications, Parasitic | 1 | 2006 | 1 | 0.250 |
Why?
|
| Neurocysticercosis | 1 | 2006 | 4 | 0.250 |
Why?
|
| Chronobiology Phenomena | 1 | 2005 | 1 | 0.230 |
Why?
|
| Subarachnoid Space | 1 | 2005 | 5 | 0.230 |
Why?
|
| Double-Blind Method | 5 | 2017 | 565 | 0.230 |
Why?
|
| Drug Therapy, Combination | 3 | 2016 | 292 | 0.220 |
Why?
|
| Rheumatic Heart Disease | 1 | 2004 | 2 | 0.220 |
Why?
|
| Bradycardia | 1 | 2004 | 17 | 0.220 |
Why?
|
| Obstetric Labor Complications | 1 | 2004 | 18 | 0.210 |
Why?
|
| Heart Arrest | 1 | 2004 | 42 | 0.210 |
Why?
|
| Pain | 3 | 2013 | 304 | 0.210 |
Why?
|
| Nerve Block | 1 | 2004 | 57 | 0.210 |
Why?
|
| Pre-Eclampsia | 1 | 2004 | 62 | 0.200 |
Why?
|
| Time Factors | 3 | 2016 | 2205 | 0.200 |
Why?
|
| Kyphosis | 1 | 2002 | 7 | 0.190 |
Why?
|
| Anesthesia, Conduction | 1 | 2002 | 24 | 0.180 |
Why?
|
| Punctures | 1 | 2022 | 32 | 0.180 |
Why?
|
| Predictive Value of Tests | 2 | 2016 | 883 | 0.180 |
Why?
|
| Doxorubicin | 1 | 2002 | 76 | 0.180 |
Why?
|
| Cardiomyopathies | 1 | 2002 | 67 | 0.180 |
Why?
|
| Pregnancy Complications | 1 | 2002 | 109 | 0.170 |
Why?
|
| Obesity | 2 | 2006 | 1111 | 0.170 |
Why?
|
| Infant, Newborn | 4 | 2009 | 666 | 0.170 |
Why?
|
| Cohort Studies | 2 | 2016 | 1840 | 0.160 |
Why?
|
| Databases, Factual | 2 | 2016 | 368 | 0.160 |
Why?
|
| Regression Analysis | 2 | 2013 | 273 | 0.150 |
Why?
|
| Preoperative Care | 2 | 2013 | 125 | 0.150 |
Why?
|
| Recovery of Function | 1 | 2019 | 239 | 0.140 |
Why?
|
| Injections, Spinal | 3 | 2014 | 119 | 0.130 |
Why?
|
| Parasympathomimetics | 1 | 2017 | 4 | 0.130 |
Why?
|
| Antineoplastic Agents | 1 | 2002 | 595 | 0.130 |
Why?
|
| Blood Patch, Epidural | 1 | 2016 | 2 | 0.120 |
Why?
|
| Blood Volume | 1 | 2016 | 9 | 0.120 |
Why?
|
| Retrospective Studies | 3 | 2016 | 3626 | 0.120 |
Why?
|
| Survival Analysis | 1 | 2016 | 477 | 0.110 |
Why?
|
| Exercise | 1 | 2019 | 603 | 0.110 |
Why?
|
| North Carolina | 2 | 2016 | 1300 | 0.110 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 2240 | 0.100 |
Why?
|
| Sterilization, Tubal | 2 | 2004 | 6 | 0.100 |
Why?
|
| Intraoperative Care | 1 | 2013 | 52 | 0.100 |
Why?
|
| Parturition | 1 | 2013 | 9 | 0.100 |
Why?
|
| Acoustic Stimulation | 1 | 2013 | 121 | 0.090 |
Why?
|
| Linear Models | 1 | 2013 | 425 | 0.090 |
Why?
|
| Models, Statistical | 1 | 2013 | 187 | 0.090 |
Why?
|
| Anxiety | 1 | 2013 | 190 | 0.090 |
Why?
|
| Space Perception | 1 | 2011 | 30 | 0.090 |
Why?
|
| Atrial Fibrillation | 2 | 2006 | 410 | 0.080 |
Why?
|
| Attention | 1 | 2011 | 84 | 0.080 |
Why?
|
| Reaction Time | 1 | 2011 | 123 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2016 | 3416 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 757 | 0.080 |
Why?
|
| Ligamentum Flavum | 1 | 2010 | 1 | 0.080 |
Why?
|
| Optical Phenomena | 1 | 2010 | 6 | 0.080 |
Why?
|
| Optical Fibers | 1 | 2010 | 4 | 0.080 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2010 | 32 | 0.080 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2010 | 40 | 0.080 |
Why?
|
| Morphine | 2 | 2010 | 50 | 0.080 |
Why?
|
| Air | 1 | 2009 | 7 | 0.080 |
Why?
|
| Postpartum Period | 2 | 2013 | 36 | 0.080 |
Why?
|
| Pneumothorax | 1 | 2009 | 8 | 0.070 |
Why?
|
| Pulmonary Fibrosis | 1 | 2009 | 12 | 0.070 |
Why?
|
| Drug Combinations | 1 | 2009 | 101 | 0.070 |
Why?
|
| Clonidine | 1 | 2009 | 64 | 0.070 |
Why?
|
| Depression, Postpartum | 1 | 2008 | 10 | 0.070 |
Why?
|
| Infusions, Intravenous | 1 | 2008 | 97 | 0.070 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2008 | 26 | 0.070 |
Why?
|
| Administration, Oral | 1 | 2008 | 200 | 0.070 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2008 | 47 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 276 | 0.070 |
Why?
|
| Pregnancy Outcome | 2 | 2009 | 86 | 0.060 |
Why?
|
| Labor, Induced | 1 | 2006 | 17 | 0.060 |
Why?
|
| Anticonvulsants | 1 | 2006 | 59 | 0.060 |
Why?
|
| Health Status | 1 | 2008 | 355 | 0.060 |
Why?
|
| Monitoring, Physiologic | 1 | 2006 | 77 | 0.060 |
Why?
|
| Factor Analysis, Statistical | 1 | 2006 | 76 | 0.060 |
Why?
|
| Pain Threshold | 1 | 2006 | 93 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2006 | 212 | 0.060 |
Why?
|
| Incidence | 3 | 2016 | 1241 | 0.060 |
Why?
|
| Oxytocin | 1 | 2005 | 29 | 0.060 |
Why?
|
| Aging | 1 | 2011 | 942 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2006 | 504 | 0.050 |
Why?
|
| Mitral Valve Stenosis | 1 | 2004 | 9 | 0.050 |
Why?
|
| Total Quality Management | 1 | 2004 | 17 | 0.050 |
Why?
|
| Combined Modality Therapy | 1 | 2006 | 555 | 0.050 |
Why?
|
| Anesthetics | 1 | 2004 | 21 | 0.050 |
Why?
|
| Anesthesia, General | 1 | 2004 | 30 | 0.050 |
Why?
|
| Labetalol | 1 | 2004 | 3 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2004 | 165 | 0.050 |
Why?
|
| Magnesium Sulfate | 1 | 2004 | 13 | 0.050 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2004 | 59 | 0.050 |
Why?
|
| Monitoring, Intraoperative | 1 | 2004 | 40 | 0.050 |
Why?
|
| Sufentanil | 1 | 2003 | 6 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2004 | 122 | 0.050 |
Why?
|
| Hemodynamics | 1 | 2004 | 164 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2008 | 1425 | 0.050 |
Why?
|
| Quality of Life | 1 | 2008 | 964 | 0.050 |
Why?
|
| Cocaine-Related Disorders | 1 | 2003 | 125 | 0.050 |
Why?
|
| Comorbidity | 2 | 2013 | 565 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2019 | 2316 | 0.040 |
Why?
|
| Stroke | 1 | 2004 | 691 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2019 | 308 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2010 | 413 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 853 | 0.030 |
Why?
|
| Heart Rate, Fetal | 2 | 2009 | 9 | 0.030 |
Why?
|
| Male | 3 | 2011 | 19441 | 0.030 |
Why?
|
| Risk Factors | 2 | 2013 | 3934 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 2013 | 69 | 0.020 |
Why?
|
| Evoked Potentials, Visual | 1 | 2011 | 6 | 0.020 |
Why?
|
| Signal Detection, Psychological | 1 | 2011 | 4 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2011 | 62 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2011 | 75 | 0.020 |
Why?
|
| Cues | 1 | 2011 | 65 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2011 | 167 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 471 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2011 | 327 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2010 | 94 | 0.020 |
Why?
|
| Conscious Sedation | 1 | 2009 | 24 | 0.020 |
Why?
|
| New York | 1 | 2008 | 20 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2009 | 116 | 0.020 |
Why?
|
| Acute Disease | 1 | 2008 | 253 | 0.020 |
Why?
|
| Middle Aged | 2 | 2011 | 11851 | 0.020 |
Why?
|
| Paresthesia | 1 | 2005 | 8 | 0.010 |
Why?
|
| Catheterization | 1 | 2005 | 55 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2009 | 861 | 0.010 |
Why?
|
| Apgar Score | 1 | 2003 | 8 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 3900 | 0.010 |
Why?
|
| Uterine Contraction | 1 | 2003 | 8 | 0.010 |
Why?
|
| Birth Weight | 1 | 2003 | 46 | 0.010 |
Why?
|
| Aged | 1 | 2011 | 10263 | 0.010 |
Why?
|